# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007860
Filing Date
2022-05-09
Accepted
2022-05-09 16:44:50
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | olma-20220331x10q.htm iXBRL | 10-Q | 1569915
2 | EX-31.1 | olma-20220331xex31d1.htm | EX-31.1 | 13580
3 | EX-31.2 | olma-20220331xex31d2.htm | EX-31.2 | 13351
4 | EX-32.1 | olma-20220331xex32d1.htm | EX-32.1 | 10409
| Complete submission text file | 0001558370-22-007860.txt |  | 5661466

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | olma-20220331.xsd | EX-101.SCH | 33649
6 | EX-101.CAL | olma-20220331_cal.xml | EX-101.CAL | 47096
7 | EX-101.DEF | olma-20220331_def.xml | EX-101.DEF | 99366
8 | EX-101.LAB | olma-20220331_lab.xml | EX-101.LAB | 355174
9 | EX-101.PRE | olma-20220331_pre.xml | EX-101.PRE | 254898
55 | EXTRACTED XBRL INSTANCE DOCUMENT | olma-20220331x10q_htm.xml | XML | 870550

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 22905763
SIC: 2834 Pharmaceutical Preparations